---
title: "HYBIO: Acetate Atosiban Injection has obtained marketing authorization in Vietnam"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253949280.md"
description: "HYBIO announced that the company has received the \"Drug Registration Certificate\" issued by the Drug Administration of the Ministry of Health of Vietnam, granting market approval for its product \"Atosiban Acetate Injection\" in Vietnam. This medication is suitable for pregnant women with indications of preterm labor, used to delay imminent preterm birth, with good clinical efficacy and minimal side effects. The market approval of this medication will further enrich the company's overseas product pipeline and expand its overseas market. The company will actively promote the sales of this medication in overseas markets to enhance its international brand influence and overall competitiveness"
datetime: "2025-08-21T08:58:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253949280.md)
  - [en](https://longbridge.com/en/news/253949280.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253949280.md)
generator: "portal-rs"
---

# HYBIO: Acetate Atosiban Injection has obtained marketing authorization in Vietnam

HYBIO announced that the company has received the "Drug Registration Certificate" issued by the Drug Administration of the Ministry of Health of Vietnam, granting marketing approval for its product "Atosiban Acetate Injection" in Vietnam. This medication is suitable for pregnant women with indications of preterm labor, used to delay imminent preterm birth, with good clinical efficacy and minimal side effects. The marketing approval of this drug will further enrich the company's overseas product pipeline and expand its overseas market. The company will actively promote the sales of this drug in overseas markets to enhance its international brand influence and overall competitiveness

### Related Stocks

- [300199.CN](https://longbridge.com/en/quote/300199.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Eric Sprott holds 95,768,929 Silver Storm shares, or 11.6% stake](https://longbridge.com/en/news/296653286.md)
- [OncoZenge registers 772,797 shares in directed issue after SEK 5 million payment from Sichuan Yangtian](https://longbridge.com/en/news/296607308.md)
- [Patagonia Gold says Rio Negro labor authority orders temporary partial suspension at Calcatreu project](https://longbridge.com/en/news/296604755.md)
- [UN candidate Baki vows focus on conflict prevention, UN renewal](https://longbridge.com/en/news/296525849.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**